Pfizer Must Face NYU Cancer Drug Royalties Row, Court Says
A New York appeals court revived New York University's 2013 lawsuit against Pfizer Inc. over royalties for cancer medicine Xalkori, which the school claimed it was instrumental in developing, finding in...To view the full article, register now.
Already a subscriber? Click here to view full article